The upper midwest health study: Gliomas and occupational exposure to chlorinated solvents

Occupational and Environmental Medicine

Volumn 70, Issue 2, 2013, Pages 73-80

  Ruder, Avima M ^a   Yiin, James H ^a   Waters, Martha A ^a   Carreón, Tania ^a   Hein, Misty J ^a   Butler, Mary A ^a   Calvert, Geoffrey M ^a   Davis King, Karen E ^a   Schulte, Paul A ^a   Mandel, Jack S ^b   Morton, Roscoe F ^c   Reding, Douglas J ^d   Rosenman, Kenneth D ^e   Stewart, Patricia A ^f  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c MERCY MEDICAL CENTER   (United States)

^d MARSHFIELD CLINIC   (United States)

^e MICHIGAN STATE UNIVERSITY   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,1,1 TRICHLOROETHANE; CARBON TETRACHLORIDE; CHLOROFORM; DICHLOROMETHANE; GLUTATHIONE TRANSFERASE M3; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; TETRACHLOROETHYLENE; TRICHLOROETHYLENE;

ADULT; AGED; ARTICLE; BIBLIOGRAPHIC DATABASE; BLOOD BRAIN BARRIER; BLOOD SAMPLING; CANCER RISK; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; GENOTYPE; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL CANCER; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK REDUCTION; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENE DELETION; GENOTYPE; GLIOMA; GLUTATHIONE TRANSFERASE; HUMANS; HYDROCARBONS, CHLORINATED; MALE; MIDDLE AGED; MIDWESTERN UNITED STATES; OCCUPATIONAL EXPOSURE; POLYMORPHISM, GENETIC; RISK FACTORS; SOLVENTS; YOUNG ADULT;

EID: 84872774208     PISSN: 13510711     EISSN: 14707926     Source Type: Journal    
DOI: 10.1136/oemed-2011-100588     Document Type: Article

References (45)

1. Ruder AM. Potential health effects of occupational chlorinated solvent exposure. Ann N Y Acad Sci 2006;1076:207-27.
2. International Agency for Research on Cancer. Carbon tetrachloride. IARC Monogr Eval Carcinog Risks Hum 1999;71:401-32.
3. International Agency for Research on Cancer. Dry cleaning, some chlorinated solvents and other industrial chemicals. IARC Monogr Eval Carcinog Risks Hum 1995;63:33-477.
4. International Agency for Research on Cancer. 1,1,1-Trichloroethane. IARC Monogr Eval Carcinog Risks Hum 1999;71(Pt 2):881-903.
5. International Agency for Research on Cancer. Chloroform. IARC Monogr Eval Carcinog Risks Hum 1999;73:131-82.
6. International Agency for Research on Cancer. Dichloromethane. IARC Monogr Eval Carcinog Risks Hum 1999;71(Pt 1):251-315.
7. Caldwell J, Lunn R. Dichloromethane, methylene chloride. In: Straif K, Cogliano V, eds. Identification of research needs to resolve the carcinogenicity of high-priority IARC carcinogens. Lyon, France: International Agency for Research on Cancer, 2010:106-19.
8. Caldwell J, Lunn R, Ruder AM. Trichloroethylene. In: Straif K, Cogliano V, eds. Identification of research needs to resolve the carcinogenicity of high-priority IARC carcinogens. Lyon, France: International Agency for Research on Cancer, 2010:120-44.
9. Caldwell J, Lunn R, Ruder AM. Tetrachloroethylene. In: Straif K, Cogliano V. Identification of research needs to resolve the carcinogenicity of high-priority IARC carcinogens. Lyon, France: International Agency for Research on Cancer, 2010:145-58.
10. Ward EM, Schulte PA, Straif K, et al. Research recommendations for selected IARC-classified agents. Environ Health Perspect 2010;118:1355-62.
11. Heineman EF, Gao YT, Dosemeci M, et al. Occupational risk factors for brain tumors among women in Shanghai, China. J Occup Environ Med 1995;37:288-93.
12. Rodvall Y, Ahlbom A, Spännare B, et al. Glioma and occupational exposure in Sweden, a case-control study. Occup Environ Med 1996;53:526-37.
13. Thomas TL, Fontham ET, Norman SA, et al. Occupational risk factors for brain tumors. A case-referent death-certificate analysis. Scand J Work Environ Health 1986;12:121-7.
14. Thomas TL, Stewart PA, Stemhagen A, et al. Risk of astrocytic brain tumors associated with occupational chemical exposures. A case-referent study. Scand J Work Environ Health 1987;13:417-23.
15. Heineman EF, Cocco P, Gomez MR, et al. Occupational exposure to chlorinated aliphatic hydrocarbons and risk of astrocytic brain cancer. Am J Ind Med 1994;26:155-69.
16. Gomez MR, Cocco P, Dosemeci M, et al. Occupational exposure to chlorinated aliphatic hydrocarbons: job exposure matrix. Am J Ind Med 1994;26:171-83.
17. Cocco P, Heineman EF, Dosemeci M. Occupational risk factors for cancer of the central nervous system (CNS) among US women. Am J Ind Med 1999;36:70-4.
18. Birner G, Richling C, Henschler D, et al. Metabolism of tetrachloroethene in rats: identification of N'-(dichloroacetyl)-L-lysine and N'-(trichloroacetyl)-L-lysine as protein adducts. Chem Res Toxicol 1994;7:724-32.
19. Custodio AC, Almeida LO, Pinto GR, et al. GSTP1 Ile105Val polymorphism in astrocytomas and glioblastomas. Genet Mol Res 2010;9:2328-34.
20. Pinarbasi H, Silig Y, Gurelik M. Genetic polymorphisms of GSTs and their association with primary brain tumor incidence. Cancer Genet Cytogenet 2005;156:144-9.
21. Coutinho P, Sandim V, Oliveira JA, et al. Lack of association between glutathione S-transferase polymorphisms and primary glioma in a case-control study in Rio de Janeiro. Genet Mol Res 2010;9:539-44. doi: 10.4238/vol9-1gmr753 (published Online First 2010/04/15).
22. De Roos AJ, Rothman N, Brown M, et al. Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors. Neurooncol 2006;8:145-55.
23. Schwartzbaum JA, Ahlbom A, Lonn S, et al. An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors. Cancer Epidemiol Biomarkers Prev 2007;16:559-65.
24. Diedrich A, Bock HC, Konig F, et al. Expression of glutathione S-transferase T1 (GSTT1) in human brain tumours. Histol Histopathol 2006;21:1199-207.
25. Wrensch M, Kelsey KT, Liu M, et al. Glutathione-S-transferase variants and adult glioma. Cancer Epidemiol Biomarkers Prev 2004;13:461-7.
26. De Roos AJ, Rothman N, Inskip PD, et al. Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev 2003;12:14-22.
27. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 2000;463:247-83.
28. Thrall KD, Gies RA, Muniz J, et al. Route-of-entry and brain tissue partition coefficients for common superfund contaminants. J Toxicol Environ Health A 2002;65:2075-86.
29. Ruder AM, Waters MA, Carreon T, et al. The Upper Midwest Health Study: a case-control study of primary intracranial gliomas in farm and rural residents. J Agric Saf Health 2006;12:255-74.
30. Ruder AM, Carreon T, Butler MA, et al. Exposure to farm crops, livestock, and farm tasks and risk of glioma: the Upper Midwest Health Study. Am J Epidemiol 2009;169:1479-91.
31. Percy C, Van Holten V, Muir C. International classification of diseases for oncology. Geneva, Switzerland: World Health Organization, 1990.
32. Chen H, Ward MH, Tucker KL, et al. Diet and risk of adult glioma in eastern Nebraska, United States. Cancer Causes Control 2002;13:647-55.
33. Hein MJ, Waters MA, Ruder AM, et al. Statistical modeling of occupational chlorinated solvent exposures for case-control studies using a literature-based database. Ann Occup Hyg 2010;54:459-72.
34. Bakke B, Stewart PA, Waters MA. Uses of and exposure to trichloroethylene in U.S. industry: a systematic literature review. J Occup Environ Hyg 2007;4:375-90.
35. Gold LS, De Roos AJ, Waters M, et al. Systematic literature review of uses and levels of occupational exposure to tetrachloroethylene. J Occup Environ Hyg 2008;5:807-39.
36. Szklo M, Nieto FJ. Epidemiology: beyond the basics. Sudbury, MA: Jones and Bartlett Publishers, 2007.
37. Flegal KM, Keyl PM, Nieto FJ. Differential misclassification arising from nondifferential errors in exposure measurement. Am J Epidemiol 1991;134:1233-44.
38. Buffone GJ, Darlington GJ. Isolation of DNA from biological specimens without extraction with phenol. Clin Chem 1985;31:164-5.
39. Daly AK, Cholerton S, Armstrong M, et al. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility. Environ Health Perspect 1994;102:55-61.
40. Pemble S, Schroeder KR, Spencer SR, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994;300:271-6.
41. Chenevix-Trench G, Young J, Coggan M, et al. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis 1995;16:1655-7.
42. Lai R, Crevier L, Thabane L. Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumors: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2005;14:1784-90.
43. Yan H, Parsons DW, Jin G, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009;360:765-73.
44. Yan H, Bigner DD, Velculescu V, et al. Mutant metabolic enzymes are at the origin of gliomas. Cancer Res 2009;69:9157-9.
45. Steenweg ME, Jakobs C, Errami A, et al. An overview of L-2-hydroxyglutarate dehydrogenase gene (L2HGDH) variants: a genotype-phenotype study. Hum Mutat 2010;31:380-90.